Rare Cancers – more common than you think
ESMO Video Commentary:
Novelties in head and neck cancer
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
20 May 2016
Vitamin E a potential biomarker for development of brain tumors
Researchers at Umeå University in Sweden and the Cancer Registry of Norway have studied possible causes behind the development of brain tumours.
12 May 2016
International collaboration for genome analysis leads to clues about rare cancer
Researchers have joined together to improve understanding about one of the most rare and lethal types of cancer: adrenocortical carcinoma
03 May 2016
Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy.
Inhibition of Antiapoptotic proteins using a BH3 mimetic increases leiomyosarcoma sensitivity to doxorubicin.